HeartSciences Inc.
HeartSciences Inc. (HSCS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HSCS · as of Jun 8, 2026
Key Statistics
Explore HeartSciences Inc. Data
hscs stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 100.0%
The HSCS analyst consensus is Buy, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $3.00, representing +64.65% upside from the current price of $1.82.
Competitors & Peers
hscs competitorsHSCS
AMIX
BCLI
BMRA
GBS
IBOStock Performance
Full HistoryAbout HeartSciences Inc.
HeartSciences Inc. a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardi…
what is heartsciences inc. · hscs stock overview · heartsciences inc. company profile · who is heartsciences inc. ceo · hscs NASDAQ · heartsciences inc. headquarters · heartsciences inc. business segments
About Stock Overview & Key Data
HeartSciences Inc. (HSCS) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Jun 16, 2022. As of the latest trading session, HSCS stock price is $1.82, with a market capitalization of $3.9M. The stock has returned -48.69% over the past 12 months and -41.39% year-to-date.
According to 3 Wall Street analysts, the consensus rating for HeartSciences Inc. stock is Buy, with an average 12-month price target of $3.00. In fiscal year 2025, HeartSciences Inc. reported revenue of $4350.00 and net income of -$8.8M. For detailed data — including HeartSciences Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, HeartSciences Inc. (HSCS) stock price is $1.82. The stock is traded on NASDAQ under the ticker symbol HSCS. The 52-week range is $1.63 – $6.47.